NCT06650930

Pharmacokinetics of Oral Calcium Carbonate in Parturients

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Stanford University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.

Conditions

• Pregnancy
• Pharmacokinetics
• Postpartum Hemorrhage

Interventions

Type	Name	Description
DRUG	Oral calcium carbonate	All participants receive a single, open-label dose of oral calcium carbonate 3000mg

Timeline

• Start date: 2025-01-01
• Primary completion: 2025-08-01
• Completion: 2025-10-01
• First posted: 2024-10-21
• Last updated: 2024-11-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study